| Psoriasis: Treatment and Pathogenesis | Lifetime | 72 | IT 3 | 99.29 |
| Dermatology and Skin Diseases | Lifetime | 141 | IT 4 | 99.17 |
| Spondyloarthritis Studies and Treatments | Lifetime | 94 | IT 7 | 98.89 |
| Autoimmune Bullous Skin Diseases | Lifetime | 212 | IT 16 | 98.33 |
| Dermatological and COVID-19 studies | Lifetime | 43 | IT 4 | 96.50 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 328 | IT 28 | 97.90 |
| Retinoids in leukemia and cellular processes | Lifetime | 468 | IT 30 | 96.26 |
| Pharmaceutical studies and practices | Lifetime | 692 | IT 16 | 95.68 |
| Urticaria and Related Conditions | Lifetime | 790 | IT 57 | 94.28 |
| Biosimilars and Bioanalytical Methods | Lifetime | 665 | IT 33 | 91.17 |
| Pregnancy and Medication Impact | Lifetime | 982 | IT 35 | 91.98 |
| Skin Diseases and Diabetes | Lifetime | 492 | IT 42 | 87.96 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 241 | IT 34 | 87.83 |
| Therapeutic Uses of Natural Elements | Lifetime | 453 | IT 51 | 86.85 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 19 | IT 2 | 99.54 |
| Dermatological and COVID-19 studies | 2021-2025 | 6 | IT 4 | 96.78 |
| Dermatology and Skin Diseases | 2021-2025 | 57 | IT 9 | 99.11 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 31 | IT 2 | 98.78 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 45 | IT 5 | 98.06 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 301 | IT 14 | 97.00 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 108 | IT 10 | 93.99 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 330 | IT 37 | 95.07 |
| Pharmaceutical studies and practices | 2021-2025 | 227 | IT 10 | 88.73 |
| Urticaria and Related Conditions | 2021-2025 | 218 | IT 18 | 91.68 |
| Asthma and respiratory diseases | 2021-2025 | 828 | IT 96 | 92.68 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 548 | IT 61 | 91.63 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 788 | IT 86 | 85.14 |
| Drug-Induced Adverse Reactions | 2021-2025 | 380 | IT 37 | 81.02 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 545 | IT 78 | 80.18 |
| Nail Diseases and Treatments | 2021-2025 | 825 | IT 55 | 71.40 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 661 | IT 61 | 65.65 |
| Vitamin C and Antioxidants Research | 2021-2025 | 598 | IT 54 | 62.48 |
| Skin and Cellular Biology Research | 2021-2025 | 513 | IT 24 | 64.13 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 519 | IT 69 | 61.67 |
| Skin Diseases and Diabetes | 2021-2025 | 392 | IT 41 | 56.95 |
| Dermatological and Skeletal Disorders | 2021-2025 | 478 | IT 78 | 56.44 |
| Parvovirus B19 Infection Studies | 2021-2025 | 939 | IT 99 | 53.75 |
| Dermatological diseases and infestations | 2021-2025 | 793 | IT 40 | 41.37 |
| Therapeutic Uses of Natural Elements | 2021-2025 | 887 | IT 99 | 18.79 |
